Newsfeeds - Spark Newswire

1 minute read

ADMA Biologics Stock Gains On FDA Approval For Plasma Collection Facility

Today, 10:01 PM

The FDA has approved ADMA Biologics Inc’s (NASDAQ:ADMA) BioCenters plasma collection facility in Maryville, Tennessee. The plasma collection facility commenced operations…

ADMA

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 10:01 PM

ADMA

2 minute read

FDA
News

ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Maryville, TN

By Benzinga Newsdesk

Today, 10:01 PM

ADMA Biologics, Inc. (NASDAQ:ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that it

ADMA

1 minute read

HC Wainwright & Co. Maintains Buy on ADMA Biologics, Lowers Price Target to $6

By Benzinga Newsdesk

Today, 10:01 PM

HC Wainwright & Co. analyst Raghuram Selvaraju maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and lowers the price target from $7 to $6.

ADMA

5 minute read

The Daily Biotech Pulse: FDA Rejects FibroGen’s Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

By Shanthi Rexaline

Today, 10:01 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10)

ACAD

11 minute read

Earnings Scheduled For August 11, 2021

By Benzinga Insights

Today, 10:01 PM

Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter.

ACVA

3 minute read

News

ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics’ Persona Technology for NexSys Plasma Collection System

By Benzinga Newsdesk

Today, 10:01 PM

ADMA

1 minute read

Legal
News

ADMA Biologies Granted U.S. Patent Titled ‘Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection’

By Benzinga Newsdesk

Today, 10:01 PM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5552&f=G&l=50&d=PTXT&p=112&S1=20210810&OS=20210810&RS=20210810

ADMA

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 10:01 PM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

2 minute read

FDA
News

ADMA Biologics reports Successful Completion Of Its FDA Pre-Approval Manufacturing Facility Inspection

By Benzinga Newsdesk

Today, 10:01 PM

Approval for VanRx Fill-Finish Machine Expected in the Second Half of 2021 All Supply Chain Robustness Initiatives Remain on Schedule RAMSEY, N.J. and BOCA RATON, Fla., July 20, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics,

ADMA